Intractable & Rare Diseases Research

Scope & Guideline

Elevating Understanding, Enhancing Lives.

Introduction

Welcome to the Intractable & Rare Diseases Research information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Intractable & Rare Diseases Research, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2186-3644
PublisherINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
Support Open AccessNo
CountryJapan
TypeJournal
Convergefrom 2012 to 2024
AbbreviationINTRACTABLE RARE DIS / INTRACTABLE RARE DIS. RES.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT, TOKYO 00000, JAPAN

Aims and Scopes

The journal 'Intractable & Rare Diseases Research' focuses on the complex landscape of rare and intractable diseases, providing a platform for innovative research that addresses both clinical and scientific challenges. Its aim is to enhance understanding, diagnosis, and treatment of these conditions through rigorous analysis and interdisciplinary collaboration.
  1. Epidemiology of Rare Diseases:
    The journal emphasizes the importance of understanding the prevalence and distribution of rare diseases, including comprehensive epidemiological studies that highlight the burden these conditions place on healthcare systems.
  2. Genetic and Molecular Research:
    Research on the genetic underpinnings of rare diseases is a core focus, including studies on genetic mutations, biomarkers, and the development of genetic diagnostics that facilitate better patient management.
  3. Clinical Management and Treatment Approaches:
    Papers often explore novel treatment strategies and management protocols for rare diseases, including case studies, clinical trials, and reviews that contribute to improved patient outcomes.
  4. Patient-Centered Research:
    The journal prioritizes research that includes patient perspectives, quality of life assessments, and psychosocial impacts of living with rare diseases, fostering a holistic understanding of these conditions.
  5. Innovative Technologies in Rare Disease Research:
    There is a consistent interest in the application of advanced technologies, such as artificial intelligence and metabolomics, to improve diagnostics, treatment efficacy, and understanding of disease mechanisms.
The journal has identified and embraced several emerging themes that reflect the evolving landscape of rare disease research. These trends highlight areas of growing importance and potential impact on clinical practice and patient care.
  1. Integration of Artificial Intelligence in Rare Disease Research:
    A significant trend is the increasing incorporation of artificial intelligence technologies in diagnosing and managing rare diseases, showcasing innovative methodologies that enhance precision medicine.
  2. Focus on Quality of Life and Patient Experiences:
    There is a growing emphasis on understanding the quality of life and psychological impacts of rare diseases, indicating a shift towards more holistic patient-centered research.
  3. Innovations in Genetic Diagnostics:
    Emerging themes include advances in genetic diagnostics, such as whole-exome sequencing and next-generation sequencing technologies, which are revolutionizing the understanding and management of genetic disorders.
  4. Interdisciplinary Collaborations:
    Research that involves interdisciplinary approaches, combining insights from genetics, epidemiology, and clinical practice, is increasingly prominent, reflecting the complex nature of rare diseases.
  5. Emerging Treatments and Therapeutics:
    There is a rising interest in novel therapeutic approaches, including gene therapies and personalized medicine strategies, that promise to address unmet needs in rare disease treatment.

Declining or Waning

While the journal has seen a rich variety of themes over the years, certain areas appear to be declining in prominence. This may reflect shifts in research focus or advancements in knowledge and technology that have rendered some topics less critical.
  1. General Reviews of Rare Diseases:
    There has been a noticeable decrease in broader reviews of rare diseases as more targeted, specific studies emerge. The focus is shifting towards in-depth analyses rather than general overviews.
  2. Historical Perspectives:
    Papers that provide historical context or retrospective analyses of rare diseases are appearing less frequently, suggesting a trend towards more forward-looking research that emphasizes current issues and future directions.
  3. Basic Science without Clinical Relevance:
    Research that delves into basic science aspects of rare diseases without a clear clinical application or relevance is becoming less common, as the journal increasingly favors studies that bridge the gap between laboratory findings and clinical practice.
  4. Epidemiological Studies in Developed Regions:
    There appears to be a waning interest in epidemiological studies focused solely on developed countries, likely as the journal aims to highlight the global burden of rare diseases, particularly in under-researched regions.

Similar Journals

Clinical Medicine & Research

Advancing clinical excellence through innovative research.
Publisher: MARSHFIELD CLINICISSN: 1539-4182Frequency: 4 issues/year

Clinical Medicine & Research is a premier peer-reviewed journal published by Marshfield Clinic, dedicated to advancing the field of medical science with a focus on clinical and community-based care. Established in 2003, the journal showcases groundbreaking research and innovative practices aimed at improving patient outcomes and optimizing healthcare delivery. With an ISSN of 1539-4182 and an E-ISSN of 1554-6179, it has garnered recognition in the academic community, achieving a Q2 ranking in Community and Home Care and a Q3 ranking in Miscellaneous Medicine categories as of 2023. The journal’s Scopus rankings further emphasize its relevance, placing it at #263 in General Medicine and #20 in Community and Home Care. Although it operates under a subscription model, Clinical Medicine & Research remains pivotal for researchers, professionals, and students seeking to stay informed about the latest advancements in clinical practice and healthcare methodologies, with an eye toward its impact on the broader medical landscape through 2024 and beyond.

Expert Opinion on Orphan Drugs

Fostering insights for the future of rare disease therapies.
Publisher: TAYLOR & FRANCIS LTDISSN: 2167-8707Frequency: 12 issues/year

Expert Opinion on Orphan Drugs is a pivotal academic journal published by Taylor & Francis Ltd, focusing on the burgeoning field of orphan drugs, which are often essential for treating rare diseases. As an integral source of insights and advancements from 2013 to 2024, this journal aims to bridge the gap between emerging scientific research and clinical application, providing a platform for authors to discuss pharmacological innovations and policy implications. With its ISSN 2167-8707, the journal has established a reputably rigorous editorial process and is indexed in Scopus, showcasing its relevance with ranks in various pharmacology and health policy disciplines. Though currently not an open-access journal, it endeavors to deliver high-quality articles that are vital for researchers, healthcare professionals, and policy makers aiming to navigate the complexities and challenges in the orphan drug landscape. It is categorized in Q4 for Health Policy and Q3 for Pharmacology in recent evaluations, reflecting its accessible yet scholarly contributions to this niche area of medical research.

Annals of Medicine and Surgery

Bridging Disciplines for Enhanced Patient Care
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2049-0801Frequency: 12 issues/year

Annals of Medicine and Surgery is a reputable multidisciplinary journal published by Lippincott Williams & Wilkins, focusing on a broad range of topics pertinent to both medicine and surgery. With an ISSN of 2049-0801, this journal aims to disseminate innovative research findings and clinical studies that contribute to the advancement of medical and surgical practices. Since its inception in 2012, it has established itself within the academic community, achieving a Q3 ranking in both the Medicine (miscellaneous) and Surgery categories for 2022. Despite its coverage being discontinued in Scopus, the journal continues to receive attention, ranked in the 45th percentile for its fields, illustrating its growing influence. Researchers, healthcare professionals, and students will find in this journal an invaluable resource for enhancing their understanding and staying updated with evolving medical and surgical landscapes. Access options are currently managed through institutional subscriptions, ensuring the dissemination of high-quality research to a diverse audience.

Boletin de Pediatria

Fostering Collaboration for a Healthier Tomorrow
Publisher: EDICIONES ERGON SAISSN: 0214-2597Frequency: 4 issues/year

Boletin de Pediatria is a distinguished journal dedicated to the field of pediatric medicine, serving as a valuable resource for researchers, clinicians, and students alike. Published by EDICIONES ERGON SA, this journal is committed to advancing the knowledge and practice of pediatric healthcare. With its ISSN 0214-2597 and E-ISSN 2340-5384, it strives to disseminate high-quality, peer-reviewed research that addresses the latest advancements and best practices in pediatrics. Although specific impact factor data is not currently available, the journal's rigorous publication standards maintain its reputation within the scientific community. Notably, while Boletin de Pediatria is not an open-access journal, it provides digital access options that ensure the wide distribution of critical pediatric research. With a commitment to improving child health outcomes, this journal plays an essential role in fostering innovation and collaboration among pediatric healthcare professionals globally.

Biomedical Reports

Innovating research for a healthier tomorrow.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9434Frequency: 6 issues/year

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.

Clinical Pathology

Navigating the Evolving Landscape of Clinical Pathology
Publisher: SAGE PUBLICATIONS LTDISSN: 2632-010XFrequency: 1 issue/year

Clinical Pathology, an esteemed journal published by SAGE Publications Ltd, stands at the forefront of advancing knowledge in the intersection of histology, microbiology, and pathology. As an Open Access journal since 2019, it provides researchers and healthcare professionals seamless access to high-quality, peer-reviewed articles that contribute to the field's growing body of knowledge. With a focus on enhancing diagnostic methodologies and advancing clinical applications, Clinical Pathology serves a diverse audience eager to explore innovative research and practical insights. The journal currently holds Q3 status in Histology and Pathology and Forensic Medicine, and Q4 in Medical Microbiology, reflecting its commitment to rigorous scholarship within a competitive landscape. Its ranking in Scopus further positions it as a vital resource for professionals striving for excellence in clinical and experimental pathology. We invite researchers, students, and professionals to engage with the latest findings and share their valuable contributions to help propel the field forward.

YONAGO ACTA MEDICA

Elevating Peer-Reviewed Medicine to New Heights
Publisher: TOTTORI UNIV MEDICAL PRESSISSN: 0513-5710Frequency: 4 issues/year

YONAGO ACTA MEDICA, published by Tottori University Medical Press, is a prominent journal in the field of Medicine, recognized for its contributions and academic rigor since its inception in 1965. With an ISSN of 0513-5710 and E-ISSN of 1346-8049, this journal is situated in Japan and spans significant periods of convergence from 1965 to 1977 and from 1986 to 2024. Classified within the Q3 category of Medicine (Miscellaneous) and holding a respectable Scopus rank of 275 out of 636 in General Medicine, YONAGO ACTA MEDICA offers an invaluable platform for researchers, professionals, and students to disseminate innovative studies and findings in diverse medical topics. While the journal currently does not operate under an open-access model, it remains committed to promoting academic excellence and advancing medical knowledge through peer-reviewed publications. Address inquiries and contributions to 86 NISHI-CHO, YONAGO, TOTTORI-KEN 683-8503, JAPAN.

IDCases

Advancing knowledge in infectious disease management.
Publisher: ELSEVIER SCI LTDISSN: 2214-2509Frequency: 1 issue/year

Welcome to IDCases, a peer-reviewed open access journal published by Elsevier Science Ltd that has been at the forefront of infectious disease research since 2014. With a ISSN of 2214-2509, IDCases is dedicated to the publication of high-quality case reports and novel findings in the field of infectious diseases, aiming to enhance clinical practice and guide therapeutic decision-making. Positioned in the Q3 Quartile of the infectious diseases category, and ranked #213 out of 344 in Scopus’s Medicine _ Infectious Diseases category, the journal establishes essential connections between academia and the healthcare community. As an open access journal, IDCases ensures that critical research is disseminated widely, fostering collaboration and innovation in managing infectious diseases. By encouraging submissions that explore both common and rare infections, global outbreaks, and novel therapeutic approaches, IDCases serves as a critical resource for researchers, healthcare professionals, and students alike. Join us in advancing the discourse and understanding of infectious diseases!

KLINISCHE PADIATRIE

Empowering Child Health with Peer-Reviewed Insights
Publisher: GEORG THIEME VERLAG KGISSN: 0300-8630Frequency: 6 issues/year

KLINISCHE PADIATRIE is a prominent academic journal published by GEORG THIEME VERLAG KG since its inception in 1972. Based in Germany, this journal serves as a valuable resource for professionals and researchers in the fields of Pediatrics, Perinatology, and Child Health. With an ISSN of 0300-8630 and E-ISSN 1439-3824, it features a rich array of peer-reviewed articles that focus on child health and development, encompassing clinical practices, therapeutic advances, and interdisciplinary approaches to pediatric care. While the journal operates on a subscription basis, its impact within the academic community is evidenced by its ranking of Q3 in Pediatrics, Perinatology, and Child Health as of 2023, and it maintains a solid standing within Q4 in Medicine (miscellaneous). The journal aims to bridge the gap between emerging research and clinical practice, providing a platform for innovative ideas that enhance pediatric care. Researchers, medical professionals, and students alike will find KLINISCHE PADIATRIE an essential addition to their academic repertoire, fostering advancements in pediatric healthcare and enriching knowledge in this vital field.

Cold Spring Harbor Molecular Case Studies

Exploring the nexus of genetics and biomedicine.
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2373-2873Frequency: 6 issues/year

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.